On May 10, 2022, Joseph Jay P. Hagan tendered his resignation as a director of the board of directors of Zosano Pharma Corporation and as chairperson of the audit committee of the Board, effective immediately. Mr. Hagan's resignation is not based on any disagreement with the Company on any matter relating to the Company's operations, policies or practice.
Zosano Pharma Corporation
Equities
ZSAN
US98979H3012
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |